AnderssonL.: Fibrinolysis in patients with prostatic cancer. Acta Chir. Scand., 126; 172 (1963).
2.
BecopoulosT., KranidesA., Mandalaki-YanitsiotisT., LouizouK., PanagiotopoulouE., DimopoulosC.: Syndrome de coagulation intravasculaire disséminée (C.I.D.) et cancer de la prostate. J. d'Urol., 86; 467 (1980).
3.
BlombäckM., EdsmyrF., KoekumC., PaulC.: Blood coagulation studies in patients with advanced carcinoma of the prostate treated with 2,6-cis-Diphenylhexamethylcyclote-trasiloxane or Estramustine-17-Phosphate. Urol. Res., 6; 95 (1978).
4.
ChohanI. S., VermylenJ., SinghI.: Sodium acetate buffer. A diluent of choice in the clot lysis time technique. Tromb. Diathes. Haemorrh., 33; 226 (1975).
5.
CostantiniA., DoniA., RizzoM., PaneraiA., GrechiG., BartolettiL.: Manifestazioni trombo-emorragiche di interesse urologico. Atti Soc. It. Urol., 1; 1 (1971).
6.
GoodnightS. H.Jr.: Bleeding and intravascolar clotting in malignancy: a review. Ann. New York Academy Sci., 230; 271 (1974).
7.
MillerS. P., Sanchez-AvalosJ., StefanskiT., ZuckermanL.: Coagulation disordes in cancer. I. Clinical and laboratory studies. Cancer, 20; 145 2(1967).
8.
PeckS. D., ReiquamC. W.: Disseminated intravascular coagulation in cancer patients: supportive evidence. Cancer, 31; 1114 (1973).
9.
PellmanC. M., RidlonH. C., PhillipsL. L.: Manifestation and management of hypofibrinogenemia and fibrinolysis in patients with carcinoma of the prostate. J. Urol., 96; 375 (1966).
10.
PergamentM. L., SwainW. R., BlackardC. E.: Disseminated intravascular coagulation in the urologic patiente. J. Urol., 116; 1 (1976).
11.
RapaoortS. A., ChapmanC. G., AmesS. B.: Coexistent hipercoagulability and acute hipofibrinogenemia in a patient with prostatic carcinoma. Amer. J. Med., 27; 144 (1959).
12.
SamahaR. J., BrunsT. N. C., RossG. J.Jr.: Chronic intravascular coagulation in metastatic prostate cancer. Arch. Surg., 106; 295 (1973).
13.
SoongB. C. F., MillerS. P.: Coagulation disorders in cancer. III. Fibrinolysis and inhibitors. Cancer, 25; 867 (1970).
14.
SunN. C. J., BowieE. J. W., KazmierF. J., ElvebackL. R., OwenC. A.Jr.Blood coagulation studies in patients with cancer. Mayo Clin. Proc., 49; 636 (1974).
15.
SunN. C. J., McAfeeW. M., HumG. J., WernerJ. M.: Hemostatic abnormalities, a prospective study of one hundred eight patients. Amer. J. Clin. Pathol., 71; 10 (1979).
16.
TagnonH. J., WhitmoreW. F.Jr., ShulmanN. R.: Fibrinolysis in metastatic cancer of the prostate. Cancer, 5; 9 (1952).
17.
TagnonH. J., WhitmoreW. F.Jr., ShulmanN. R., KravitzS. C.: The significance of fibrinolysis occurring in patients with metastatic cancer of the prostate. Cancer, 6; 63 (1953).
18.
WuK. K., HoakJ. C.: A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet, 2; 924 (1974).
